Abstract: It is known that DNA is a well-characterized intracellular target but its size and sequential characteristics make it an elusive target for selective drug action. Binding of low molecular weight ligands to DNA causes a variety of significant biological responses. In this context the main consideration is given to recent developments in DNA sequence selective binding agents bearing conjugated effectors because of their potential application in treatment of cancers, in diagnosis as well as in molecular biology. In the present review recent results about analogues of netropsins, distamycin A and of some lexitropsins and combilexins or related hybrid molecules with sequence reading, intercalating or alkylating activity are described and evaluated for prospective applications. Furthermore there exists DNA minor groove binder with different basic structures which does not possess the typical polyamide chain, including dimeric intercalating chromophores.
INTRODUCTION
Progress in cancer research over the last 25 years has led to the inescapable conclusion that neoplasia is a malady of genes [1] [2] [3] [4] [5] . A large number of malignancies that do not respond to chemotherapy underline the need to develop safe and effective antitumour drugs. Although several potent antitumour drugs do not interact with nucleic acids, the steady accumulation of evidence that the malignant transformation of a cell for example of the blood, lung, or brain, is due to an alteration of particular genes, calls clearly for the continual development of DNA-interacting drugs or moreover for drugs that interfere with DNA enzymes or transcription factors inducing selective gene silencing. DNA is probably the best structurally characterized biopolymer, thus making it an attractive target for drug design [5] [6] [7] [8] [9] [10] [11] .
There are several possibilities how a drug that binds to DNA (alkylation, intercalation, minor/major groove binding, outside binding) or to DNA dependent enzymes -such as topoisomerases bound to DNA -achieves its biological activity [12] . Moreover in the last years investigational drug design was focused on DNA targeting through the development of code reading molecules, inhibitors of transcription factors, new topoisomerases I inhibitors and on compounds targeting the quadruplex structure resulting in telomerase inhibition [8] .
In the present review we report new findings about minor groove binding drugs originally based on the natural lead compounds netropsin 1 and distamycin A 2 as DNAsequence reading oligopeptides [9] [10] [11] (Fig. (1) ) starting from the year of 2000. The structural variants are called *Address correspondence to this author at the University of Mainz, Faculty of Chemistry and Pharmacy, Pharmaceutical and Medicinal Chemistry, D-55099 Mainz, Germany; Tel: +49 6131 3925737; Fax: +49 6131 3925620; E-mail: pindur@uni-mainz.de "lexitropsins" [10] , whereas in particular the combination of the polyamide chain with an intercalator leads to "combilexins" 3, 4, 5a,b as hybrid molecules, respectively [10, 11, 13, 14] . The general chemical structure is represented by 7. In this context of sequence reading molecules some results about peptide nucleic acids 8 and related compounds (see for example nucleobase linked derivative 6) [15] [16] [17] are also presented. In summary, these molecule series are on the one hand of general interest for anticancer/antisense therapy, and on the other hand they represent a useful tool in academic research for molecular biological operations in the context of gene manipulation or gene silencing processes [8, 18] .
During the past few years, studies have indicated that the antitumour activity of DNA-binding drugs is not due to interaction with DNA per se but is at least in part the results of the inhibition of enzymes that regulate DNA topology. In this context a number of minor groove binding drugs might exert their biological effects by interfering with DNA-protein interactions. They are in many cases dual inhibitors of topoisomerase I and II. These biochemical data suggest that these topological enzymes read DNA structure and are involved in DNA replication, transcription, recombination and chromosome segregation at mitosis [18] . Thus, presenting the recent developments of minor groove binding ligands, their effects on topoisomerase will be reported for some cases. [19] [20] [21] [22] [23] [24] . For new topoisomerase I inhibitors see exemplarily 9 and 10 [29] .
ANALOGUES OF NETROPSIN, DISTAMYCIN A, RELATED LEXITROPSINS A N D HYBRID MOLECULES
The synthesis and testing of analogues of the natural occurring oligopyrrole carboxamides is a subject of the [4, 7, 25, 26, 27] , hybrid molecules [28] , peptide nucleic acids [15, 16] and topoisomerase I-inhibitors [29] .
current active research. By understanding the processes involved in the recognition of defined DNA base sequences by lexitropsins rational modifications of the basic molecular structure could be engineered to modulate both binding affinity and DNA-site selectivity for therapeutic gain. Modifying and varying the pyrrole rings of netropsin or distamycin A to bioisosteric systems should lead to more products that are stable under most experimental conditions. Moreover, this modifying can also lead to analogues having the potential for the development as carriers for the groove specific delivery of functionalized groups of DNA and as template inhibitors of transcription. Antiparallel pairing of imidazole with pyrrole recognized a G-C base pair, whereas a pyrrole/pyrrole pair recognizes either an A-T or T-A base pair [3] . The binding constant and sequence-specificity of the pyrrole-imidazole hairpin polyamide are comparable to that of a transcription factor. Moreover, it has been found that the genes of the human immunodeficiency virus (HIV) are silenced by competitive binding of pyrrole-imidazole hairpin polyamides to their regulatory sequences [3] .
It has been shown that large DNA sequence reading oligomers of the netropsin/distamycin series have low delivery activity to the mammalian nucleus [30] . Some smaller molecules possess significant activity, but less sequence reading selectivity. Thus, forty-eight heterocyclic amino-acid trimers, analogues of distamycin, with a number of features that enhance lipophilicity for good membrane penetration, of the type 11 are described. The original distamycin patterns were varied by inserting imidazole, thiazole, thiophene and oxazole moieties. Several aliphatic substituents (for example isopropyl, 3-methylbutyl, cycloalkyl) were selectively introduced at the five ring hetarenes to increase lipophilicity (Fig. (2) ).
For the synthesis the appropriate amino substituted aromatic heterocycles were coupled by standard methods, including the use of acid chlorides, carbodiimides, and HBTU (O-benzotriazol-1-yl-N,N,N',N'-tetramethyluroniumhexafluorophosphat). The yield of coupling was typically in the range of 30-80 %. Compounds were purified by preparative HPLC. The ability of these compounds to bind predominantly to AT tracts of DNA has been evaluated 
Fig. (3).
(A) Structures of netropsin and distamycin A, the ring proton numbering is shown on the first ring of distamycin 2 for comparison with hair-pin compound 12.
(B) Ligands 12 used in ref. [31] , showing the numbering of the aromatic rings and amide protons relevant for 1H-NMR analysis.
using capillary zone electrophoresis. Significant antimicrobial activity against key organisms such as MRSA (Methicillin Resistant Stapylococcus aureus) and Candida albicans was found for several compounds, especially those containing a thiazole. Moreover, these compounds showed low toxicity with respect to several mammalian cell lines. Perhaps, these lipophilic distamycin analogues may be substrates for biological transporters [30] .
Over the past several years a special design has emerged for sequence specific DNA ligands which target the minor groove and that are related to distamycin A 2 but with a supramolecular structure comprising pyrrole (Py), hydroxypyrrole (Hp) or imidazole (Im) rings (Fig. (3) ) [31] .
These groups are linked together by amide bonds or short alkyl chains. In the DNA bound complexes two sets of rings stack side-by side across the minor groove in an antiparallel arrangement (hair-pin conformation of the ligand). Base specificity for AT or GC-sequences is given by the pyrrole or hydroxy-pyrrole rings [3, 9] . In continuation of this research the importance of N-terminal acetylation and Cterminal structure of imidazole/pyrrole polyamides of type 12 on the orientation of DNA-binding (Fig. (3) ) have been investigated [31] . The products were synthesized using solid-phase methods. NMR studies with dublex DNA and 2 D-spectra (NOESY, TOCSY, 1 H, 13 C-HMBC) were analysed, including quantitative DNase I footprinting experiments, respectively. The N-terminal acetylation leads to an intramolecular steric clash for hairpin ligands bound in the minor groove, promoting a rotation of the spatially close C -terminal pyrrole ring. This in turn leads to loss of contacts between the tail and the groove, removing the preference for 5'-to 3'-orientational binding typical of this class of ligands. Similarly, introduction of a glycine linker into the tail leads to a direct steric clash with the groove, again promoting rotation of the attached ligand ring. The effects of acetylation and a glycine in the tail are additive. These results lead to new implications for the general design of sequence-specific drugs. In Fig. (4) a schematic view of the differences in intraligand NOEs between a typical 5'-directional complex and a 3'-directional complex with an inverted C-terminal pyrrole and an acetyl group is given [31] . Moreover, in this work a molecular model was obtained by simulated annealing and energy minimisation using semiquantitative distance restraints derived from NOESY data (Fig. (5) ). In an effort to explore the sequence specificity of new ring pairs in eight-ring hairpin polyamides containing 3-substituted thiophene-2-carboxamide residues at the Nterminus new hairpin lexitropsins were synthesized by standard solid-phase techniques (Fig. (6) ) [32] . Quantitative DNase I footprinting titration and molecular modelling studies (Spartan Essential software) gave rise to interesting binding models in the minor groove of the DNA. A N-terminal 3-methoxy (or 3-choloro) thiophene residue paired opposite to pyrrole displayed 6-(and 3-) fold selectivity for TA relative to AT-base pair, while disfavouring GC base pairs > 200-fold. The data suggest shape selective recognition with projection of the 3-thiophene substituent (3-methoxy or 3-chloro) to the floor of the minor groove (see Fig. (7) ).
For hybrid pyrrole-imidazole-carboxamide molecules with hairpin binding conformation the design and solid phase synthesis of a sequence specific DNA alkylating compound was described [33] . The electrophilic functionality consists of 1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole (seco-CBI), an alkylating moiety related to the drug CC-1065. Two diastereomeric compounds (17a, 17b) were obtained that differ only in the absolute configuration of the alkylating unit (Fig. (9) ).
Alkylation yields and sequence specificity were determined on a restriction fragment containing six base pair match and mismatch sites. Alkylation was observed at a single adenine flanking the polyamide binding site, a strand selective cleavage could be achieved based on the enantiomer of seco-CBI chosen. At 1 nM concentration of polyamideseco-CBI conjugate, near quantitative cleavage was observed (Fig. 9) . contd..... after 12 h. These bifunctional molecules could be useful for targeting coding regions of genes and inhibiting transcription.
A series of head to head linked dimers of five ring heterocyclic amino acids has been prepared for analysing the affinity and selectivity of binding in the minor groove of DNA. The selection of targets for synthesis was led by computer based design. Several novel central dicarboxylic acid linkers including indoles, phenanthrenes, a fluorenone, and a bisbenzothiophene have been introduced (Fig. (10) ), [34] . As polyamide-five ring aromatic heterocycles pyrrole, imidazole, thiazole and thiophene were used. The coupling reactions were performed by standard procedures.
Analysis of binding to DNA by footprinting showed high affinity for compounds derived from 2,7-dihydrophenanthrene dicarboxylic acid (see Fig. (10) , a bisnetropsin analogue, and a predominant selectivity for AT rich regions containing at least 4 AT pairs but with the ability to span up to two GC base pairs.
An additional study of the design of DNA alkylating ligands with possible sequence specificity was performed using quinone methide precursors as DNA alkylating and cross-linking reagents [35] . The pyrrole-imidazole lexitropsin system was chosen due to its predictable association with base pairs of the minor groove and its compatibility with cellular conditions [33] . The synthesis of one compound of this ligand class is given in Fig. (11) . The crucial step is the coupling reaction of the quinone methide precursor with the pyrrole-imidazole-polyamide (18) . The product was isolated by reverse phase chromatography and the structure was confirmed by electrospray mass spectroscopy.
Another study describes gene silencing in mammalian cells by alkylating pyrrole-imidazole polyamides [36] . It is believed that gene silencing occurs via inhibition of gene expression by Py-Im polyamides binding to regulatory sequences [31, 32] . The two hybrid polyamides 19a and 19b (Fig. (12) ) cause specific gene silencing by alkylation of coding regions of the renilla and firefly luciferase in nanomolar concentration, according to the base pair recognition rule for Py-Im polyamides. Two different plasmids, encoding renilla luciferase and firefly luciferase, were used as vectors to examine the effect of alkylation on gene silencing. Furthermore the experimental results of transfection and cotransfection experiments into HeLa cells support the assumption, that these alkylating Py-Im polyamides have the potential as antitumour drugs that target specific gene expression in human cells. It is known that distamycin A 2 as minor groove binder and the drug actinomycin D as intercalator and groove binder also possess antibacterial activity because they interfere with bacterial DNA. In this context lead optimization and structure-activity relationships of DNA minor groove binding ligands, as a novel class of antibacterial ligands, are described [37] . Prototypic DNA-binding antibacterials related to distamycin A 2 are compound 20 and 21 ( Fig.  (13) ).
The synthetic optimizations were focused on N-terminal aromatic heterocycles and C-terminal amines (Fig. (14) ). The resulting compounds showed improved in vivo tolerability and excellent in vitro antibacterial potency (MIC ≥ 0,031 µg/mL) against a broad range of gram-positive pathogens, including drug-resistant strains such as methicillin-resistant Stapylococcus aureus (MRSA), penicillin-resistant 
Streptococcus pneumonia (PRSP), and vancomycin-resistant Enterococcus faecalis (VRE).
Typically, molecules which will read base pair sequences of the required 10 base pair length or more have been based on hairpin structures, as described [3] . They violate the "rule of five" in at least two respects; the molecular weight is too high (over 2000 Da) and there are to many hydrogen bond donors. Such molecules would be expected to have difficulty in passing through biological membranes and might not reach the desired site of action, even if given by injection. Thus, further detailed studies with shorter ligands of the lexitropsin series are still of interest for drug design [34] . (Fig. 14) . contd..... Footprinting capillary electrophoresis, molecular modelling and NMR studies have been used to examine the binding of the short polyamide 22 with an isopropylthiazole carboxamide group to DNA [38] .
This molecule is selective for the sequence 5'-ACTAGT-3' to which it binds with high affinity. Two molecules bind side-by-side in the minor groove, but their binding is staggered so that the molecule reads six base pairs, unlike the related natural distamycin A, which tends to bind to four-base-pair sequences.
In the context of hybrid molecules with alkylating activity the design, synthesis, characterization, DNA binding properties, and cytotoxic activity of a novel series of hybrids, namely, a molecular combination of the natural antibiotic distamycin A and the antineoplastic agent uramustine (uracil mustard), are reported and the structure activity relationships are discussed [39] . A homologue series 23a -23f was synthesized by standard coupling reactions ( Fig. (16) ).
All compounds in this series exhibit enhanced activity compared to both distamycin A and uramustine carboxylic acid derivatives used for conjugation. The IC 50 values are in the range of 7.26-0.07 µM following a 1 h exposure of human leukamic K562 cells, with maximal activity shown when n = 6. Taq polymerase stop experiments demonstrated the selective covalent binding of uramustine-distamycin hybrids to AT rich DNA-sequences. It is reported that the higher flexibility due to a longer linker between the distamycin and uracil moiety is responsible for the mustard group penetrating more deeply into the minor groove. The distamycin moiety directs binding to the minor groove of AT rich DNA-sequences and, consequently, is responsible for the regioselective alkylation found in footprinting studies (molecular modelling for the distamycin-hydrogen bond s. Moreover, a series of halogenoacrylic derivatives 24 of distamycin A are described [40] (Fig. (17) ).
The structure-activity relationships indicate a key role of the reactivity of the α-halogenoacrylic moiety. The reactivity and the putative alkylating mechanism is possibly based on a Michael type reaction. The novel compounds 24 were tested on Leukaemia L1210 cells. They were synthesized by coupling the appropriate acrylamido-pyrrole carboxylic acid with N-desformyl-distamycin dihydrochloride. In the case of n = 3, R-bromo and R-chloro-derivatives show a relevant cytotoxicity, the R-fluoro-and R-bromo-(vinyl-methyl) derivatives show a dramatic loss of activity (Fig. (17) ).
In a following study about the α -b r o m o a c r y l i c derivatives a modification of the amidine moiety of diystamycine was performed (Fig. 18) [41] . 
I n p a r t i c u l a r d u e t o a f a v o u r a b l e myelotoxicity/cytotoxicity ratio, guanidine derivative PNU 166196 was selected for further evaluation in clinical trials.
Novel benzoyl nitrogen mustard derivatives of pyrazole analogues of distamycin A were synthesized and tested for cytotoxicity [42] . Exemplarily compound 26a is more cytotoxic against leukaemia cells than polyamide 26b which possesses three instead of two pyrazole rings in the helical chain (Fig. (19) ).
Carbocyclic analogues of netropsin and distamycin A were synthesized, and studied for DNA-binding and inhibition of topoisomerases (Fig. 2 0 ) [43] . These compounds containing two or three benzene units were designed to provide improved distinction between minorgroove and intercalation binding modes. Inhibition of topoisomerase I and II was achieved only with the tribenzene analogues. Data from the ethidium displacement assay showed that these compounds were able to bind in the minor groove in AT sequences of DNA. AMBER Molecular Modelling with DNA dodecamers was performed to rationalize the lower binding affinity of the tribenzene analogues 27c, 27d in comparison to dibenzene analogues 27a, 27b. The superior DNA-binding afforded by 27a, 27b in comparison to 27c and 27d results from their more effective penetration into the minor groove of DNA and smaller perturbation of molecular structure upon complex formation.
Further aromatic analogues of netropsin with amide and aryloxy function have been investigated for cytotoxic activity with MCF-7 breast cancer cells and for inhibition of topoisomerases (Fig. (21) ) [44] . These studies indicate that aromatic analogues of bis-netropsin that contain two identical units tethered by aryl-alkyloxy chains, are potent catalytic inhibitors of both topoisomerases and exhibit moderate cytotoxicity in MCF-7 breast cancer cells.
Heteroaromatic bisamidines 40-43 have been proven to be efficient compounds against Leishmania spp. and Pneumocystis carinii [45] (see Fig. (22) ). Though the mode of action is still not known these molecules are supposed to be DNA minor groove binders. In ref. [45] a molecular modelling study for a set of minor groove binders is reported, that ranks them through their complementarity to the Dickersen Drew Dodecamer according to their interaction energies with B-DNA. A comparative molecular field analysis (CoMFA) has shown the importance of relatively bulky positively charged groups attached to the groove binding aromatic rings, as well as of small and negatively charged substituents in the middle of the chain. Reliable models were obtained in terms of independent test sets of similar groove binders. GRID molecular field analysis allotted bioisosteric substitution of −O− by −NH− in furan ring of furamidine and related compounds as being capable to enhance the binding to the DNA dodecamer. The robustness and the validation of the model for the design of analogues minor groove binders are demonstrated. 
Fig. (21).
Several hybrid molecules of the type "combilexins" (3,4) (Fig. (1) ) with DNA-intercalating and sequence reading moiety have been synthesized and characterized in full details [4, 7, 46, 47] . Some newer results will be discussed here. A trifunctional molecule 44 (Fig. (23) ) which combines a bispyrrole skeleton for minor groove DNA recognition, linked to two different chromophores, anilinoacridine and ethidium, is described [48] . The affinity and mode of binding of 44 to DNA were studied by a combination of complementary biochemical and biophysical techniques including absorption and fluorescence spectroscopy as well as circular and linear dichroism [48] . A surface plasmon resonance biosensor analysis was also performed to quantify the kinetic parameters of the drug-DNA interaction process. All three moieties of the hybrid molecule are engaged in the interaction process, validating thus the rational design strategy. At the biological level 44 stabilizes covalent complexes between topoisomerase II and DNA and shows cytotoxic activities. Moreover, compound 44 easily enters and accumulates in cell nuclei as evidenced by confocal microscopy [48] .
In the last years also a great variety of hybrid netropsin / distamycin analogues with a coplanar hetarene or anthraquinone moiety linked in contrary to compounds 3 and 4 (Fig. (1) ) at the N-terminus of the oligopyrrolecarboxamide chain were described [49] [50] [51] . From this hybrid type less information about potential sequence reading does exist so far. Moreover, less is known about topoisomerase I inhibition of this series.
The new compounds 45 (Fig. (24) ) were synthesized by standard procedures [50, 51] . The procedures for nitro group reduction and the subtle sequential amide couplings had to be revised and optimised considerably to get the highly pure polyamide compounds 45 for different reliable biophysical and biochemical assays. However, on the basis of the established cytotoxicity assays from NCI (Bethesda, USA) the carbazole derivative 45b and the nitro derivative 45f are effective growth inhibiting drugs (GI 50 about 10 -8 M) and show antitumour activity. Moreover, the pyrrole carboxamides 45a-45h inhibit topoisomerase I in a concentration of 0.05 to 50 µ M. In the case of the anthraquinone-sulfonamide 45g strong DNA-binding at poly-AT seems to be very likely. This was supported on T m -measurements on poly AT versus GC-rich calf thymus DNA, which reveals ∆T m -values of 20°C for poly-AT and 5°C for calf thymus DNA, respectively. However, the more lipophilic congener with the C-terminal methyl ester group possesses better membrane penetration. Semiempiric quantum chemistry calculations (AM1) of the single polyamides 45 predicted a low LUMO energy for those compounds with high DNA minor groove affinity according to the established frontier molecular orbital model, assuming the interaction with the HOMO of the AT-groove [50, 51] .
In a following study of the same group additional structural variants of the combilexins with an intercalating chromophore at the N-terminal end of pyrrole carboxamide were synthesized systematically to continue the structure activity relationships that are crucial for binding to DNA [52]. For the critical synthetic steps of the amide coupling reactions the procedures were newly developed and optimized in the sense of good reproduction. Unfortunately many other, not reproducible methods to related compounds are known. The anthraquinone linker was modified in respect of chain length, an acridine chromophore, an acridone and an iminostilbene tricyclic nucleus were introduced as a hybrid part (Fig. (25) ). Moreover, the structure of the chromophore was further expanded and a series of new naphthalimide linked pyrrole carboxamides were synthesized.
Some of the compounds reflect topoisomerase I inhibition and DNA binding [52] . Especially the iminostilbene derivative 50 showed significant cell cytotoxicity in the NCI screening. Summarising details of biophysical and antitumour screening results are in preparation and will be published [52] . 
MINOR GROOVE BINDER WITH DIFFERENT BASIC STRUCTURE AND FUNCTIONALITIES
New structural isomeric/dimeric analogues to bisbenzimidazole Hoechst 33258 53 (Fig. (26) ) were designed based on molecular modelling [53] . The head-to-head bisbenzimidazoles 54a, 54b, and 54c were synthesized according to the in silico approach. Especially 54b possesses the best overall potency in cell biology assays with IC 50 values down to 50 nM against several tumours. There was highly sequence selective binding across four consecutive AT base pairs of d(CGCGAATTCGCG) in the minor groove. These findings successively led to the synthesis of a dimeric analogue of 54b, compound 55 [53] (Fig. (27) ).
The novel dimeric bis-benzimidazole 55 was on the average about ten times less cytotoxic than the simpler benzimidazole 54c. However, DNA footprinting studies demonstrated that the compound had a high affinity and selectivity for the oligonucleotide sequence [AT] 4 -[GC]-[AT] 4, which is not a common motif in human DNA. QSAR and a molecular modelling study of several benzimidazoles and ligands of different structures as minor groove binders are discussed in more detail in ref. [45] .
Variants of the minor groove binder Hoechst 33258 53 inspired the design and synthesis of a new series of crescentshaped unsymmetrical cyanine dyes. The structural influence on the degree of minor groove binding to calf thymus DNA was investigated by flow linear circular dichroism (LCD) and circular dichroism (CD) (Fig. (28) ) [54] . An overview of the compounds is given in Fig. (28) . The new dyes are analogues to the minor groove binding unsymmetrical cyanine dye BEBO [54] . The new compounds comprise a 6- methylbenzothiazole/benzoxazole added to the benzothiazole and furthermore the pyridine ring was substituted by a quinoline ring.
The flow linear circular dichroism and circular dichroism studies show that the extent of minor groove binding to mixed sequence DNA varies significantly between the dyes. Hydrophobicity and size are the crucial parameters for recognition of the minor groove [54] .
Free carboxylic acids derived from the amide function of the alkylating antitumour agents mitozolomide 58 and temozolomide 59 (Fig. (29) ) were coupled to simple amino acids and peptides by carbodiimide method [55] . Also lexitropsins from the pyrrole and imidazole group were coupled to the drugs to give rise to hybrid compounds 60.
However, these potential DNA minor groove binders showed no enhanced growth-inhibition of tumour cell lines compared to the unconjugated drugs. Sites of alkylation at tracks of multiple guanines were also unaffected.
Phenylimidazole nucleosides 61b, c, d (Fig. (30) , (31)) with different substituents were synthesized and studied for their binding to a CG-Watson-Crick base pair by 1 H-NMR spectroscopic techniques in an aprotic solvent [56] . A complex formed by two hydrogen bonds with the CG-W a t s o n -C r i c k base pair is proposed (Fig. (3 0 ) ) . Concentration and temperature dependent measurements allowed the determination of association constants, association enthalpies and entropies. Strong binding was observed with analogues carrying an ureidophenyl substituent and corresponding enthalpies of association are compatible with the anticipated formation of three hydrogen bonds to the CG base pair. In contrast, only weak binding was observed for analogues with an aminophenyl or benzamidophenyl substituent. 2D NOE measurements at low temperatures confirm the proposed binding mode for the high affinity ligands [56] .
In the context of photochemistry and DNA-binding some new interesting results are described. Berenil 62a, a 1,3-triazen derivative, is a photostable DNA minor groove binding ligand. However, the N-3-hydroxypropyl derivative 62b is photosensitive to 360 nm irradiation, behaving as a caged diazonium salt [57] . Footprinting and binding studies revealed that 62b showed a strong preference for AT rich binding sites in DNA, with an affinity similar to that of b e r e n i l 6 2 a itself ( Fig. (3 2 ) ). The 4-amidinobenzenediazonium fragment produced by photolysis induces DNA modification and cleavage. rings and a groove binding cyclic peptidic chain [58] . The specifity concerning binding of the quinoxaline antibiotic depends on the peptide backbone interaction in the minor groove. For further variants of dimeric intercalators see also the following chapter. In a new study on photodynamic therapy using photosensitizing drugs the photocleaving property of novel quinoxaline-carbohydrate hybrids 64 as artificial light activatable agents is described [58] (Fig. (33) , (34) ). The cleavage reactions were analyzed with DNA and photocytotoxicity in tumour cells by irradiation. The DNA fragments were sequence analysed electrophoretically by the Sanger method. The obtained DNA photocleavage and cytotoxicity profiles gave significant information about the molecular design of novel and selective DNA photocleaving and cytotoxic agents.
The trimeric pyrrolo[e]indole derivative (+)-CC-1065
65 is one of the most potent antitumour natural products discovered [59] . Related minor groove binding alkylators are (+)-duocarmycin A 66 and (+)-duocarmycin SA 67 (Fig.  (35) ). CC-1065 analogues 68-70 (Fig. (36) ) bearing different DNA-binding subunits were synthesized [60] . A terminal C5-NO 2 or -F moiety at the DNA-binding subunit increases the drug's potency and antitumour efficacy as is tested in antitumour screening with leukaemia cells and with mice. A C5-OCH 3 group reduced the potency and antitumour efficacy. A preliminary toxicity study indicated that terminal C5-OCH 3 and -acetamido moieties at the DNA-binding subunit caused delayed death in mice.
An extensive series of cyclopropylbenzoindole (CBI) analogues of the duocarmycins and CC-1065 exploring substituent effects within the first indole DNA binding subunit is shown in Fig. (37) , (38) [61] . In general, substitution at the indole C5 position led to cytotoxic potency enhancements that can be ≥ 1000-fold providing simplified analogues containing a single DNA binding subunit that are more potent (IC 50 = 2-3 pM) than CBI-TMI, duocarmycin SA, or CC-1065. For details see 
Fig. (38).
conformationally constrained tricyclic indoles suggest a special binding in the pocket of the minor groove. An additional benefit from hydrophobic contacts by the appropriated substituents in a pocket deeply in the minor groove is discussed for controlling the rate of DNA alkylation (Fig. (38) ). However, duocarmycin A 66 was converted to a series of the O-substituted A-ring pyrrole derivatives bearing simplified DNA-binding moieties such as cinnamoyl or heteroarylacryloyl groups, and evaluated for in vitro anticellular activity against HeLa S 3 , and in vivo antitumour activity against murine sarcoma 180 in mice (Fig. (39) , (40)) [62] .
In duocarmycin A 66 the cyclopropyl bearing segment A is the alkylating group for the nucleo bases, whereas segment B is responsible for selective minor groove binding. Additional modifications were introduced in the alkylating segment A (Fig. (40 Fig. (41) . These duocarmycin derivatives bearing the simplified DNA-binding moieties showed remarkable potent in vivo antitumour activity and low peripheral blood toxicity compared with their analogues bearing the trimethoxy indole skeleton in segment B, which were equal to 8-O -[(Nmethylpiperazinyl)carbonyl] derivatives of 4'-methoxycinnamates and 4'-methoxy-ß-heteroacrylates (Fig.  (40) ). Moreover, among the 8-O-substituted analogues, several new compounds act as prodrugs: Thus, the phenolecarboxylic esters can be hydrolysed enzymatically and subsequently oxidized in vivo to the active chinonemethid derivatives (Seg-A3) [62] . All compounds 76 were synthesized from the cyclopropanoindole derivatives 77.
Substituted 4-nitrobenzyl-carbamate prodrugs of the 5-aminobenz[e]indoline class of DNA minor groove alkylating agents were prepared for gene directed enzyme-prodrug therapy. The prodrugs and effectors were tested in a cell line panel comprising parenteral and transfected human Chinese hamster and murine cell line pairs. The active compounds were released in situ from the prodrugs by using a two electron-nitroreductase from E. coli B [63] (Fig. (41) ). In human cell line pairs, several analogues 78-80 bearing neutral methoxyethoxy-, 2-hydroxyethoxy-, or 3-hydroxypropoxy-substituted side-chains were good substrates for the two-electron-nitroreductase as measured by their cytotoxicity ratio [78] [79] [80] .
The investigation of benz[e]indoles was continued by the design, synthesis and cytotoxicity evaluation of seco-CBI dimers [64] (Fig. (42) ). Cell biological results showed that the antitumour activities were strongly related to the position and length of the linker. The cytotoxic sequence of these seco-CBI dimers implies that the linking N3 amide plays a critical important role in DNA alkylation. In general, the activity sequence is C7-C7 dimers < C7-N3 dimers < N3-N3 dimers. covalent bond to the exocyclic C2-NH 2 of the central guanine [65] . Dimeric analogues 86 and 87 have been synthesized and showed markedly superior in vitro cytotoxicity (ovarian cells) and interstrand cross-linking reactivity (single cell gel-electrophoreses, COMET) compared to the monomer. Especially 87b is the most potent compound in this series. Fig. (44 a,b) shows schematic representations of the interactions of dimeric ligands and the fit of a PBD subunit within the minor groove of a host DNA duplex.
On the basis of biophysical experiments regiospecific DNA damage caused by AT selective minor groove binder, such as bizelesin, a bis-(chloromethyl-pyrroloindole) urea derivative, were reported [82] 
DIMERIC INTERCALATORS WITH GROOVE BINDING STRUCTURE ELEMENTS
There is current interest in design and synthesis of dimeric analogues of lipophilic, neutral DNA bisintercalating agents as anticancer drugs with good delivery effects for application in vivo [66, 67, 68, 70] . In the field of biscarbazoles with intercalating and minor groove binding structural elements (for example bisellipticines and ditercalinium) [12] , some novel bis(tetrahydropyrrolo [3,4-b] carbazoles) linked with aromatic, aliphatic and polyamidic chains were designed, synthesized and studied for in vitro cytotoxicity and for DNA binding (Fig. (45) ) [66] [67] [68] . The compounds were synthesized by a (Fig. 45). contd. .... indolo-2,3-quinodimethan-Diels-Alder strategy starting with bisbromomethyl-indole 88 with subsequent functionalisation reactions [66] [67] [68] (see Fig. (45) ).
The biscarbazoles 90-93 showed weak DNA binding (UV-spectrometric titration with ethidium bromide) and in most cases low cytotoxicity (NCI-screening). However, especially compound 90 gave a growth inhibition as GI 50 value of 10 -6 M of HL-60 (TB) NCI cell lines [67] .
The bis(naphthalimide) LU 79953 94 (Fig. (46) ) is a DNA bisintercalator and a very potent cytotoxin, with broadspectrum activity against a variety of human solid tumour cell lines, which is in a Phase I clinical trial [69] . In the context of these model compounds 94, 95 other coplanaric intercalating heterocycles (first of all bis-acridines) are continuously synthesized as new promising drugs [69, 70] .
Interestingly, the related bis(nitronaphthalimide) DMP 840 95 appears to be only a mono-intercalator, but shows curative activity against a variety of human solid tumour xenografts in nude mice. Phase I clinical trials have been reported. The real mode of action is unclear, but they are known to be topoisomerase inhibitors. Functionalized ringsubstituted bis(phenazine-1-carboxamido)amines 97, linked by a (CH 2 ) 3 NMe(CH 2 ) 3 -chain, were prepared from the corresponding substituted phenazine-1-carboxylic acids by reaction of their intermediate imidazolide derivatives with bis(3-aminopropyl) methylamine (Fig. (47) ). The compounds were evaluated for growth inhibitory activity in a panel of tumour cell lines, including P388 leukaemia.
Analogues with small, lipophilic substituents (e.g. Cl) at the 9-position were the most potent inhibitors, superior to the corresponding bis(acridine-4-carboxamides). Several compounds were preferably (up to 2 fold) more cytotoxic Fig. (48) . Structure of the threading diacridines studied. -N(CH 2 CH 2 ) 2 N-denotes piperazine. Fig. (49) . Molecular modelling stereodiagram of a HINT interaction map for the intercalation of doxorubicin with the CAAT base pair sequence of DNA, which displays, visually, the quality and magnitude of the various binding contacts involved in the interaction. The contour surfaces are color-coded by interaction type at a constant map density value of ± 80. Blue surfaces represent favourable polar interactions, red surfaces represent unfavourable polar interactions, green surfaces represent favourable hydrophobic interactions, and magenta surfaces represent unfavourable hydrophobic interactions. The interatomic distance between the N3á mmonium on doxorubicin's sugar ring and the carbonyl oxygen atoms of three surrounding base pairs of DNA is also indicated [72] .
toward the mutant Jurkat than wild-type lines. To test whether this selectivity was related to topoisomerase action, the most potent of the compounds (9-methyl) was evaluated in a cell free system. It poisoned topoisomerase I at drug concentrations of 0.25 and 0.5 µ M and inhibited the catalytic activity of both topoisomerase I and topoisomerase II at concentrations of 1 and 5 µM, respectively. Results from the NCI's human tumour cell line panel showed that the compound had preferential activity toward colon cancer tumour lines. In particular the 9-methyl compound was substantially more potent in a colon 38 tumour model in vivo than the clinical dual topoisomerase I/II poison DACA 96 (X= CH) (Fig. (46) , (47)).
New bisintercalating threading diacridines 98 as a series of bis(9-aminoacridine-4-carboxamides) were synthesized.
They were linked via the 9-position with neutral or cationic flexible alkyl or alkylamino chains [71] (Fig. (48) ). These compounds are designed to bisintercalate into the DNA by a threading mode, in which the side chains are intended to form hydrogen-bonding contacts with O6/N7 atoms of guanine in the major groove, and the linkers are intended to lie in the minor groove. DNA helix unwinding assay, DNA dissociation kinetic, cell line cytotoxicity and flow cytometry were performed. Indeed, both the diethylaminoethyl and morpholino dimer series bisintercalate into DNA by the threading mode, in which they place the 4-carboxamide side chain in one groove, and the interchromophore linker in the other. The compounds appear to have binding sites extending over four base pairs in which the middle two are sandwiched by the acridine chromophores. This binding mode results in a substantial slowing of dissociation rates, as indicated by preliminary kinetic findings, so that the lifetimes of the bisintercalated complexes begin to approach those of known template transcription inhibitors. Cytotoxicity varies markedly depending on linker type.
Anthracycline antibiotics represent a well known prototype of mono intercalating and groove binding drugs which can be considered as lead compounds for the development of new bisintercalating and minor groove binding drugs [12] . In this context a computational model for anthracycline binding to DNA was described in the sense of tuning groove-binding intercalators for specific sequences [72] . There has been intense interest in the DNA binding sequence specificity of these compounds in recent years, with the hope that a compound could be identified that could possibly modulate gene expression or display reduced toxicity. In this context computational models (free energy calculations) of 65 doxorubicin analogues and their complexes with eight distinct DNA octamer sequences (the HINT-Hydrophathic Interactions program was used) were utilized to describe binding, including differences in the functional group contributions as well as sequence selectivity. Of these 65 compounds, two compounds were calculated to have a selectivity greater than -0.75 kcal mol -1 for one sequence over all others. 10 compounds were specific between -0.50 and -0.74 kcal mol -1 . 18 compounds were specific between -0.25 and -0.40 kcal mol -1 , and 35 compounds were virtually nonspecific with a ∆∆ G below -0.24 kcal mol -1 . Among other results the removal of the methoxy group at the C4 position on the aglycone portion also appears to add potency and selectivity (idarubicin drug). In summary, analyzing of the free energy of binding and sequence selectivity of both known and designed analogues of doxorubicin will lead to a reliable predicting model to identify future lead compounds for further experimental research. Fig. (49) shows a stereodiagram of a HINT interaction map for the intercalation of doxorubicin with the CAAT base pairs sequence of DNA, which displays the quality and magnitude of the various binding contacts involved in the interaction [72] .
PEPTIDE NUCLEIC ACIDS AND RELATED NUCLEIC ACID BASE LINKED POLYAMIDES
Peptide nucleic acids (PNAs) are recently described as DNA mimetics, in which the sugar-phosphate backbone is replaced by N-(2-aminoethyl)glycine units [15] [16] [17] 73] . A structural comparison of a peptide chain and a PNA molecule interacting with a normal DNA strand is given in Fig. (50) . This figure also illustrates the DNA mimicking character of PNA which represents -from a formal point of view -DNA with a pseudopeptide skeleton.
These molecules efficiently hybridize with complementary DNA, forming Watson-Crick double helices. They bind preferentially in the major groove. In addition, PNAs and PNA based analogues are especially attractive because they are resistant to DNases and proteinases. While application of PNAs as antisense and antigene molecules in non-viral gene therapy is well documented [17, 73] , their effects as potential transcription factor decoy molecules is not demonstrated [73] . Moreover, the newer double stranded molecules based on PNA-DNA chimeras (Fig. (51) ) exhibit strong transcription factor decoy activity, enzymatic stability in serum and cellular extracts and can be delivered to target cells after complexation with liposomes and microspheres. These PNA-DNA chimeras can be further engineered by addition of short peptides facilitating cell penetration and nuclear localization [73] .
In this context synthesis and hybridization properties of DNA-PNA-chimeras carrying 5-bromouracil and 5-methylcytosine were described in detail [74] . The synthesis of the PNA monomers using the monomethoxytrityl protecting group is given in Fig. (52) , (53) . These PNA monomers were used for the preparation of several DNA-PNA chimeras on the basis of solid-phase protocols by using an aminohexyl-linker fixed at polyethyleneglycolpolystyrene [74] . Duplex and triplex stabilization of the new oligomers were investigated by UV-spectroscopic T m value measurements (single strand, double helix, triple helix, hairpin). Substituting 5-methylcytosine for cytosine in DNA-PNA chimeras increased duplex stability, while 5-bromouracil for thymine maintained it. Moreover, binding of DNA-PNA chimeras to double-stranded DNA to form triple helices was studied. In contrast to natural DNA, which contains also purine-bases, the presence of 5-methylcytosine and 5-bromouracil in DNA-PNA chimeras destabilized triple helix [74] .
The specificity of DNA-protein interaction served as a model to select DNA-binding ligands from synthesized peptide libraries containing some unnatural amino acids on solid support [75] . The DNA-binding ligands from the peptide libraries were screened for double-stranded DNA. For this purpose, the dyes fluorescein and rhodamine were used to label the single-stranded oligodesoxynucleotides. This solid support bound products with affinity to DNA turned red in visible light and fluoresced yellow in UV light. A similar technique can be used for the selection of ligands which bind to hairpin RNA, using a monolabelled oligonucleotide. The screening process revealed a high structure-affinity relationship in the successful products. Only six out of the twelve unnatural amino acids were selected with the repeated appearance of 3-(uracil-1-yl)-alanine, N-methylglycine and the secondary amino acids hydroxyproline, 4-carboxypiperidine. The affinity and selectivity for the target was determined using a DNase I protection assay. The technique described may be useful for identifying new sequence specific DNA-and DNA-binding ligands able to interfere with gene expression.
'Retro-inverso' peptide nucleic a cids (PNA monomers) of thymine (T*: N-(amidomethyl)-N-(N 1 -thyminylacetyl)-ß-alanyl) (and adenine) were introduced in PNA oligomers [76] (Fig. (54) ). A homo 'retro-inverso' T* 8 oligonucleotide, whereas introduction of one 'retro inverso' thymine unit into the middle of a normal PNA 15-mer resulted in a ∆T m ca. 8 o C destabilization of the complex of this oligomer with a complementary DNA or RNA oligomer. In an effort to compensate for the structural nucleobase 'phase shift' caused by the T* monomer by also introducing a ß-alanine monomer it is concluded that the effect of the T* backbone is a melting point reduction of 7°C when hybridizing to DNA and a reduction of 4,5°C when hybridizing to RNA. The T* unit shows good sequence discrimination comparable to that of normal PNA. Molecular dynamics simulations indicate an unfavourable conformation of the backbone amide carbonyl group resulting in reduced interaction with the aqueous medium and the 'electrostatic clash' with the carbonyl of the nucleobase linker. These results show that a simple inversion of an amide bond in the PNA backbone has a dramatic, and hardly predictable, effect on the DNA mimicking properties of the oligomer.
For the discovery of novel sequence-specific DNA binding ligands further solution phase screening was done with new unnatural oligopeptides with DNA pyrimidine selectivity [77] . These studies delivered a new DNA binding peptide to a DNA sequence (NF binding site of IL6). This octapeptide has the sequence Ac-Arg-Ual-Sar-Chi-Chi-TalArg-CONH 2 (for unnatural amino acids see Fig. (55) ). The contribution of the different amino acid side chains to the binding strength of the peptide to the DNA was investigated in detail using an ethidium displacement test. The strongest DNA binding was observed using {[(3-chlorophenyl)methyl]amino}acetic acid (Cbg) and ß-cyclohexyl-1-alanine (Cha) respectively, at those two positions. Moreover, a 10-fold increase in affinity compared to the Ual-Sar sequence was obtained. A further enhancement of DNA binding was obtained with hybrid molecules of type 99 linking the newly developed peptide fragment to an acridine derivative with a flexible spacer (Fig. (56) ). This resulted in ligands with affinities in the µM range for a DNA target (K d of 2.1 x 10 -6 M, gel mobility shift-assay). DNase I footprinting with the newly developed oligopeptide motifs showed the presence of a pronounced pyrimidine specificity, while conjugation to an intercalator seems to redirect the interaction to mixed sequences.
By the formation of telomeric DNA, "guanine" rich strand formed in tetrades the acceptor-donor functions of the guanines are capable to produce simultaneous pairing via Watson-Crick-and Hoogsteen-site. Moreover it is known [78] that also cytosine rich oligomers can form such tetrades, albeit pyrimidines possess no Hoogsteen site and do not contribute significantly to the stabilization by base stacking of the DNA. In this context analogues of the DNA-i-motif [78] were synthesized on the basis of the alanyl-PNA skeleton. For the study of the C-C-pairing in a possible tetrade (Fig. (57) ) octameric H-(AlaC-AlaC) 4 -Lys-NH 2 100 and H-(AlaC-AlaC) 4 -Lys-NH 2 ) ent-100 and the glycine-AlaC Fig. (60) . Schematic procedure of random screening, using the library and magnetic beads. analogues 101 were synthesized [AlaC = ß-(cytosin-1-yl)alanin]. The pairing activity was studied by the melting curves [78] . However, a tetramer organisation of the glycineAlaC-oligomer 101 was observed including gelfiltration HPLC. NMR-ROESY spectra support these findings (Fig.  (58) ).
A successful and rapid screening of DNA-binding peptide ligands from a solid-phase combinatorial library with the use of target DNA-conjugated magnetic beads was reported [79] . The target-duplex 104 (Fig. (59) ) has a polyether linker between two complementary sequences (T 4 A 3 G-ether linker -CT 3 A 4 ) and is stable in the dublex form during the selection procedure. Finally, 71 pentapeptide sequences were identified from the solid-phase pentapeptide library 102. From a peptide sequence analysis most of the peptide ligands possess hydrophobic amino acids as the major component. The synthetic peptides with identified sequences possess mostly hydrophobic amino acids as major components have exhibited moderate to high binding affinity to the duplex DNA in competition experiments with ethidium-DNA complexes [79] (Fig. (59) , (60)).
In a new report a thymine-PNA monomer as an isocyanide component in the Ugi-reaction was used for a direct entry to PNA dimers 105 [80] (see Fig. (61) , (62)). With this procedure also PNA dimers were accessible labelled with Cr(CO) 3 . These PNA dimers could be used for further synthesis of dimers also in a combinatorial manner. For metal derivatives of peptide nucleic acid oligomers additional studies are described and a new chemistry was developed [81] .
Lexitropsins, combilexins and related hybrid molecules as well as peptide nucleic acids are well documented as mimic compounds for DNA protein interactions with multiple interaction sites and sequence reading properties. Ongoing progress as well as many successful developments is reported in this review. However, functionally closely related to these groups is a novel series of lexitropsins In analogy to netropsin an AT-binding of the compounds 106-111 was supposed. At least the nucleobase-coupled bispyrrole derivatives induced a slight increase of the melting temperature of poly AT-DNA and a hypochromic and bathochromic shift in the UV-spectra in presence of calf thymus DNA. A positive signal in the CD-spectra of drugs with DNA proved the interaction with the minor groove. Biochemical experiments with topoisomerases I and II of these promising candidates revealed that there is no inhibition of these enzymes. Moreover all the nucleic acid derived compounds were inactive in the cytotoxicity assay of the NCI screening program. This is probably related to poor membrane permeability because of the hydrophilicity of the nucleobases [calculated log P values (lipophilicity) of compounds 106-111 are throughout negative].
CONCLUSION
In the last years a variety of new DNA ligands of the lexitropin and combilexin series were synthesized. Significant DNA sequence reading effects were described in view of gene targeted drugs. The significance of base specifity of DNA ligand also in cleavage reactions for rational drug design and targeting was demonstrated. Moreover peptide nucleic acids or related nucleic acid linked hybrid molecules are promising candidates as DNA antigene models. A variety of the hybrid compounds have significant antitumour activity and inhibit topoisomerases. They have the potential as lead compounds for the development of antitumour active drugs. The overall result given in this report is a challenge for chemists to develop high sequencespecific compounds. Moreover the results should enable to create compounds which possess good cell penetration and unimpeded interaction with DNA in cellular and higher systems. 
ABBREVIATIONS

